CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $0.59 | $4K | 2,183,972 |
| 2025-08-24 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −723 | $0.59 | $424 | 201,222 |
| 2025-08-24 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −1,434 | $0.59 | $841 | 748,243 |
| 2025-08-24 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,792 | $0.59 | $1K | 744,487 |
| 2025-08-24 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,792 | $0.59 | $1K | 766,089 |
| 2025-07-22 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −31,866 | $0.48 | $15K | 746,279 |
| 2025-07-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −126,950 | $0.48 | $61K | 2,191,460 |
| 2025-07-22 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −31,866 | $0.48 | $15K | 749,677 |
| 2025-07-22 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −31,866 | $0.48 | $15K | 767,881 |
| 2025-07-22 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −6,708 | $0.48 | $3K | 201,945 |
| 2025-06-12 | Smith Karen L. Director | Grant or award | +25,000 | 102,100 | ||
| 2025-06-12 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-06-12 | PARKER H STEWART Director | Grant or award | +25,000 | 112,600 | ||
| 2025-06-12 | PARKER H STEWART Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-06-12 | Meyers James R Director | Grant or award | +25,000 | 99,600 | ||
| 2025-06-12 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-06-12 | Markels John Director | Grant or award | +25,000 | 96,384 | ||
| 2025-06-12 | Markels John Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-06-12 | Horn Margaret A Director | Grant or award | +25,000 | 82,650 | ||
| 2025-06-12 | Horn Margaret A Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 3 of 9 · 165 trades